Aethlon Medical raises $4.0M in follow-on offering priced at $0.71/unit

AETHLON MEDICAL INC

Gross proceeds of ~$4.0M from sale of common stock, pre-funded warrants, and warrants; net proceeds ~$3.335M.
Offering includes 5.63M common warrants exercisable at $0.71 per share, subject to stockholder approval.
Maxim Group acted as sole placement agent; received 6.25% cash fee and 225,320 placement agent warrants.
Proceeds to be used for working capital, R&D, clinical trials, and potential acquisitions.
Lock-up agreements for officers and directors for 90 days; company restricted from issuing securities for 90 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.